Eye2Gene is a research project funded by the National Institute for Health and Care Research (NIHR), based at UCL Institute of Ophthalmology and Moorfields Eye Hospital. Its aim is to develop artificial intelligence that can predict (from images acquired using the Heidelberg retinal scanner) which type of inherited retinal disease the patient has, and specifically which gene is likely to be affected. Once validated, Eye2Gene can help make decisions about patient care.
Heidelberg Engineering is a global leader in ophthalmic imaging and data technologies which is widely used by eye care specialists working on inherited retinal diseases.
The two organisations just announced their collaborative partnership at the ARVO 2024 Annual Meeting in Seattle. Eye2Gene lead, UCL Institute of Ophthalmology Population and Data Sciences Deputy Theme lead, Dr Nikolas Pontikos said:
Given that our Eye2Gene AI has been trained on Heidelberg imaging, this represents a significant step forward in the product development pathway of the Eye2Gene medical technology. We hope to leverage this exciting opportunity to accelerate the validation and piloting of our technology within the NHS and internationally with real-world evidence, so that eventually more people affected by inherited retinal diseases will receive a genetic diagnosis and the care they need.“Given that our Eye2Gene AI has been trained on Heidelberg imaging, this represents a significant step forward in the product development pathway of the Eye2Gene medical technology. We hope to leverage this exciting opportunity to accelerate the validation and piloting of our technology within the NHS and internationally with real-world evidence, so that eventually more people affected by inherited retinal diseases will receive a genetic diagnosis and the care they need.Given that our Eye2Gene AI has been trained on Heidelberg imaging, this represents a significant step forward in the product development pathway of the Eye2Gene medical technology. We hope to leverage this exciting opportunity to accelerate the validation and piloting of our technology within the NHS and internationally with real-world evidence, so that eventually more people affected by inherited retinal diseases will receive a genetic diagnosis and the care they need.
DCAL Paid Internship Opportunities
Are you deaf and interested in language, psychology or neuroscience research? We offer paid Research Placement opportunities. Come and work with us!
05 Mar 2026
UCL GBSH Student of the Week: Sarah Tomkins
A lifelong health leader driven by equity and system change, DBA student Sarah brings decades of frontline, executive and VCSE experience to her research on culture, leadership and integration.
05 Mar 2026
From movement to cognitive maps: AI models show how learning to move shapes the brain's maps.
A new study reveals that how young animals learn to move may shape how their brains build navigation maps, offering key insights into how early experiences wire the developing brain.
04 Mar 2026